Article Text

PDF
THU0521 Enthesitis-related arthritis: non-peripheral pattern is associated with th17 cells
  1. M Katsicas,
  2. C Carrara,
  3. A Bernasconi,
  4. J Rossi,
  5. R Russo
  1. Immunology & Rheumatology, Hospital de Pediatría Garrahan, Buenos Aires, Argentina

Abstract

Background Enthesitis-related arthritis (ERA) is a category of juvenile idiopathic arthritis. Different proinflammatory cytokines linked to the Th1 and Th17 T- cell subsets have been implicated in its pathogenesis. Limited data are currently available about the relationship between disease activity and the clinical pattern and the percentage of Th1and Th17 T- cell subsets.

Objectives To analyze Th1 and Th17 cell subsets in patients with ERA and to compare with age-matched healthy controls. To assess the association between disease activity and disease clinical pattern with Th1and Th17 cells subsets

Methods Patients with ERA (according to ILAR criteria) were included in a cross sectional study. Disease activity measures were collected in random visits: active joint count (AJ), pain score (0–10), presence of active enthesitis (AE), sacroiliac pain (SIP), lumbar pain (LP),lumbar limitation (LL) by Schöber's test, wellbeing according to the patient using a visual analogue scale (VASp, 0–10), disease activity according to the physician (VASphy, 0–10), JADAS-10, JSpADA, and ESR/CRP were evaluated. Patients were classified based on the disease pattern (peripheral and non-peripheral) depending on the presence or absence of AJ and/or AE. Functional capacity was also assessed by CHAQ. Presence of radiologic sacroiliitis (MRI/X-rays) and treatment with TNF inhibitors (TNFi) were recorded. Th-17 and Th-1 cells were quantified by flow cytometry in PBMCs stimulated with PMA/IO. Age-matched healthy children without disease or medication were recruited as normal control. Comparison between groups (Mann-Whitney Utest) and correlation tests as appropiate

Results Twenty-nine patients (90% M) fulfilled inclusion criteria. HLA-B27 was positive in 13 (45%). Median age at observation was 12 years and median disease duration was 2.1 years. Activity and functional measures were (medians): AJ 1, pain 0.25, VASp 0.5, VASphy 1, JADAS-10 7, JSpADA 1.75, ESR 15 mm/h, and CHAQ ≥0,5=8 patients (27%). AE was present in 1 (3%), SIP in 7 (24%), LP in 6 (21%), and LL in 12 (41%) children. Nineteen (65%) patients showed JADAS >1 and 21 (76%) JSpADA>0. Radiologic sacroilitis was recorded in 21 (72%) children. Fourteen (48%) patients were treated with TNFi. Th1cell percentage in ERA was 8.5±3.4% (range, 4–17.4) while healthy controls was 5.8±3.8% (range, 1.2–14.2), p=0.023. Th17cell% in ERA was 0.90±0.44 (range, 0.39–2.34%) while controls was 0,55±0.38 (range, 0,17–1,61%); p=0.004. There was no difference between T-cells% and active/inactive disease. Eighteen (62%) children showed peripheral pattern, while 11 (38%) exhibited non-peripheral. Peripheral and non-peripheral groups showed Th17%cells 0.90 (0.39–1.74) vs 1.14 (0.64–2.44) respectively (p=0.018).Significant correlations were Th1 with AJ (r=0.45 p=0.004) and Th17with LP (r=0.83 p=0,0001), LL (r=0.47 p=0.03).

Conclusions Th1 and Th17 cells subsets were significantly higher in ERA compared with healthy controls. However, T-cells showed no significant difference between patients with active versus inactive disease. Interestingly, non-peripheral pattern showed higher Th17% cells respect to patients with peripheral disease.Our results suggest that Th17 evaluation could help identify different phenotypes that benefit from Th-17 blocking strategies.

References

  1. Biologic agents in juvenile spondyloarthropathies. Katsicas MM, Russo R. Pediatr Rheumatol Online J.2016Mar 12;14 (1):17.

References

Disclosure of Interest None declared

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.